Digital health decision makers recently gathered in Los Angeles, CA, at ViVE 2024 to share ideas for governance and regulation of artificial intelligence tools, like large language models. While their efforts are necessary, one thing is becoming clear: regulating the near-term risk of misuse of biological AI tools could be impossible.
There are a growing number of disparate attempts at developing approaches to contain the uses of this quickly evolving technology. There are country-specific recommendations, such as those issued in November 2022 by the UK BioIndustry Association
